Hologic
HOLX • NASDAQ
Hologic is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Stephen MacMillan, with a market cap of $16.9B.
CEOStephen MacMillan
Next Earnings
Upcoming earnings announcement for Hologic
Date
Thursday, April 30, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
$1.07
Revenue Estimate
$1.0B
Earnings History
Past 12 earnings reports for Hologic
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Q1 2026 | $1.04Est: $1.10 | -5.5% | $1.0BEst: $1.1B | -2.2% |  10-Q |
| Nov 3, 2025 | Q4 2025 | $1.13Est: $1.10 | +2.7% | $1.0BEst: $1.0B | +1.6% | 10-K |
| Jul 30, 2025 | Q3 2025 | $1.08Est: $1.05 | +2.9% | $1.0BEst: $1.0B | +1.5% | 10-Q |
| May 1, 2025 | Q2 2025 | $1.03Est: $1.02 | +1.0% | $1.1BEst: $1.0B | +5.5% | 10-Q |
| Feb 5, 2025 | Q1 2025 | $1.03Est: $1.02 | +1.0% | $1.0BEst: $1.0B | +0.2% | 10-Q |
| Nov 4, 2024 | Q4 2024 | $1.01Est: $1.01 | 0.0% | $987.9MEst: $976.7M | +1.1% | 10-K |
| Jul 29, 2024 | Q3 2024 | $1.06Est: $1.02 | +3.9% | $1.0BEst: $1.0B | +1.1% | 10-Q |
| May 2, 2024 | Q2 2024 | $1.03Est: $0.98 | +5.1% | $1.0BEst: $1.0B | +1.8% | 10-Q |
| Feb 1, 2024 | Q1 2024 | $0.98Est: $0.95 | +3.2% | $1.0BEst: $986.1M | +2.7% | 10-Q |
| Nov 9, 2023 | Q4 2023 | $0.89Est: $0.84 | +6.0% | $945.3MEst: $940.0M | +0.6% | — |
| Jul 31, 2023 | Q3 2023 | $0.93Est: $0.88 | +5.7% | $984.4MEst: $957.1M | +2.8% | — |
| May 1, 2023 | Q2 2023 | $1.06Est: $0.88 | +20.5% | $1.0BEst: $958.8M | +7.1% | — |